{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreibwmkouwoo4gj4sxo3geg6k5bumdmnn7qlfae7ssuos3npaslcafi",
    "uri": "at://did:plc:dk3cidiehe4vsvmqef7yc475/app.bsky.feed.post/3mk4tv7ylujm2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreicd5zmb4cevl5bdi4yv5uygk4fopdxbccxfgsnoykshdt6g3dnsba"
    },
    "mimeType": "image/png",
    "size": 1943528
  },
  "path": "/new-review-casts-doubt-on-alzheimers-drugs-but-is-controversial/?utm_source=rss&utm_medium=rss&utm_campaign=new-review-casts-doubt-on-alzheimers-drugs-but-is-controversial",
  "publishedAt": "2026-04-22T12:49:42.000Z",
  "site": "https://sciencebasedmedicine.org",
  "tags": [
    "Alzheimer's Disease",
    "Neuroscience/Mental Health",
    "New Review Casts Doubt On Alzheimers Drugs But Is Controversial",
    "Science-Based Medicine"
  ],
  "textContent": "I have been following the story here of the newest Alzheimers drugs, the first to show that they can actually slow the progression of Alzheimer’s disease (AD). The benefits are modest, and come with the potential for serious side effects and a high price tag, but after decades of disappointment it was good to at least have a proof of concept that […]\n\nThe post New Review Casts Doubt On Alzheimers Drugs But Is Controversial first appeared on Science-Based Medicine.",
  "title": "New Review Casts Doubt On Alzheimers Drugs But Is Controversial"
}